| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Surgical Procedures, Operative | 63 | 2021 | 260 | 6.830 |
Why?
|
| Postoperative Complications | 129 | 2023 | 2678 | 6.750 |
Why?
|
| Hospitals, Veterans | 69 | 2015 | 255 | 3.340 |
Why?
|
| Vascular Surgical Procedures | 26 | 2016 | 317 | 2.460 |
Why?
|
| Quality Improvement | 26 | 2023 | 1183 | 2.370 |
Why?
|
| Risk Assessment | 51 | 2023 | 3452 | 2.250 |
Why?
|
| Patient Readmission | 12 | 2020 | 704 | 2.090 |
Why?
|
| Quality Indicators, Health Care | 19 | 2016 | 306 | 1.920 |
Why?
|
| Risk Factors | 112 | 2023 | 10366 | 1.740 |
Why?
|
| Indians, North American | 22 | 2020 | 644 | 1.680 |
Why?
|
| Preoperative Care | 17 | 2021 | 356 | 1.600 |
Why?
|
| Databases, Factual | 39 | 2023 | 1391 | 1.510 |
Why?
|
| Hospital Mortality | 21 | 2022 | 911 | 1.430 |
Why?
|
| Risk Adjustment | 16 | 2023 | 79 | 1.380 |
Why?
|
| Inpatients | 6 | 2023 | 493 | 1.340 |
Why?
|
| Logistic Models | 53 | 2023 | 2083 | 1.340 |
Why?
|
| United States | 134 | 2023 | 14983 | 1.300 |
Why?
|
| Quality Assurance, Health Care | 15 | 2009 | 328 | 1.280 |
Why?
|
| Adrenergic beta-Antagonists | 6 | 2014 | 227 | 1.100 |
Why?
|
| Aged | 136 | 2021 | 24134 | 1.090 |
Why?
|
| Ambulatory Surgical Procedures | 3 | 2023 | 66 | 1.090 |
Why?
|
| General Surgery | 9 | 2016 | 173 | 1.090 |
Why?
|
| Retrospective Studies | 75 | 2023 | 15842 | 1.060 |
Why?
|
| Humans | 280 | 2023 | 138201 | 1.040 |
Why?
|
| Oral Health | 11 | 2020 | 140 | 1.030 |
Why?
|
| Intensive Care Units | 11 | 2022 | 849 | 1.010 |
Why?
|
| Middle Aged | 158 | 2022 | 33711 | 0.990 |
Why?
|
| Perioperative Care | 6 | 2017 | 181 | 0.970 |
Why?
|
| Surgical Wound Infection | 18 | 2023 | 307 | 0.950 |
Why?
|
| United States Department of Veterans Affairs | 27 | 2013 | 684 | 0.950 |
Why?
|
| Myocardial Infarction | 10 | 2016 | 1055 | 0.920 |
Why?
|
| Treatment Outcome | 76 | 2023 | 10914 | 0.890 |
Why?
|
| Patient Admission | 3 | 2022 | 202 | 0.870 |
Why?
|
| Male | 196 | 2022 | 68035 | 0.850 |
Why?
|
| Veterans | 28 | 2017 | 1477 | 0.840 |
Why?
|
| Coronary Artery Bypass | 11 | 2006 | 231 | 0.830 |
Why?
|
| Dental Caries | 9 | 2019 | 171 | 0.820 |
Why?
|
| Female | 183 | 2023 | 73713 | 0.770 |
Why?
|
| Specialties, Surgical | 3 | 2021 | 76 | 0.760 |
Why?
|
| Models, Statistical | 14 | 2020 | 667 | 0.710 |
Why?
|
| Cohort Studies | 43 | 2023 | 5717 | 0.700 |
Why?
|
| Intensive Care Units, Pediatric | 2 | 2014 | 262 | 0.700 |
Why?
|
| Academic Medical Centers | 16 | 2009 | 507 | 0.700 |
Why?
|
| Angioplasty, Balloon, Coronary | 7 | 2006 | 142 | 0.690 |
Why?
|
| Postoperative Period | 9 | 2022 | 347 | 0.670 |
Why?
|
| Morbidity | 25 | 2022 | 319 | 0.660 |
Why?
|
| Heart Arrest | 3 | 2013 | 358 | 0.660 |
Why?
|
| Arthroplasty | 1 | 2020 | 53 | 0.650 |
Why?
|
| Aortic Aneurysm, Abdominal | 8 | 2013 | 160 | 0.650 |
Why?
|
| Adult | 88 | 2023 | 38190 | 0.620 |
Why?
|
| Physical Fitness | 1 | 2020 | 206 | 0.610 |
Why?
|
| Arthroplasty, Replacement, Hip | 9 | 2020 | 177 | 0.600 |
Why?
|
| Self Efficacy | 4 | 2020 | 400 | 0.600 |
Why?
|
| Odds Ratio | 18 | 2017 | 1080 | 0.600 |
Why?
|
| Healthcare Disparities | 3 | 2014 | 660 | 0.580 |
Why?
|
| Elective Surgical Procedures | 15 | 2021 | 183 | 0.570 |
Why?
|
| Postoperative Care | 4 | 2017 | 265 | 0.560 |
Why?
|
| Sleep Apnea, Obstructive | 4 | 2020 | 302 | 0.560 |
Why?
|
| Time Factors | 35 | 2021 | 6848 | 0.560 |
Why?
|
| Survival Rate | 22 | 2017 | 1934 | 0.550 |
Why?
|
| Electronic Health Records | 8 | 2023 | 1078 | 0.550 |
Why?
|
| Multivariate Analysis | 21 | 2019 | 1495 | 0.540 |
Why?
|
| Aged, 80 and over | 41 | 2023 | 7683 | 0.530 |
Why?
|
| Surgeons | 4 | 2023 | 311 | 0.520 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2020 | 404 | 0.520 |
Why?
|
| Angioplasty | 4 | 2009 | 47 | 0.500 |
Why?
|
| Sepsis | 5 | 2023 | 603 | 0.490 |
Why?
|
| Endarterectomy, Carotid | 6 | 2013 | 54 | 0.480 |
Why?
|
| Probiotics | 3 | 2022 | 56 | 0.480 |
Why?
|
| Pneumonia, Ventilator-Associated | 3 | 2022 | 54 | 0.480 |
Why?
|
| Mortality | 3 | 2017 | 355 | 0.480 |
Why?
|
| Private Sector | 16 | 2013 | 54 | 0.480 |
Why?
|
| Uvula | 2 | 2006 | 4 | 0.480 |
Why?
|
| Patient Discharge | 7 | 2020 | 903 | 0.460 |
Why?
|
| Pharynx | 2 | 2006 | 61 | 0.460 |
Why?
|
| Arthroplasty, Replacement, Knee | 7 | 2020 | 362 | 0.450 |
Why?
|
| Length of Stay | 21 | 2023 | 1216 | 0.450 |
Why?
|
| Comorbidity | 17 | 2022 | 1645 | 0.440 |
Why?
|
| Preoperative Period | 5 | 2021 | 136 | 0.440 |
Why?
|
| Blood Vessel Prosthesis Implantation | 2 | 2008 | 221 | 0.440 |
Why?
|
| Prospective Studies | 44 | 2017 | 7611 | 0.440 |
Why?
|
| Survival Analysis | 18 | 2017 | 1313 | 0.430 |
Why?
|
| Laparoscopy | 9 | 2023 | 446 | 0.430 |
Why?
|
| Renal Dialysis | 4 | 2017 | 436 | 0.430 |
Why?
|
| Quality of Health Care | 14 | 2008 | 651 | 0.420 |
Why?
|
| Breast Neoplasms | 6 | 2013 | 2294 | 0.400 |
Why?
|
| Emergency Treatment | 4 | 2021 | 120 | 0.400 |
Why?
|
| Pneumonia | 8 | 2023 | 640 | 0.390 |
Why?
|
| Surgery Department, Hospital | 5 | 2020 | 20 | 0.390 |
Why?
|
| Informed Consent | 4 | 2020 | 188 | 0.390 |
Why?
|
| Bariatric Surgery | 6 | 2012 | 215 | 0.390 |
Why?
|
| Myocardial Ischemia | 6 | 2020 | 259 | 0.380 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2017 | 448 | 0.380 |
Why?
|
| Smoking | 6 | 2012 | 1601 | 0.380 |
Why?
|
| Patient Satisfaction | 3 | 2020 | 678 | 0.370 |
Why?
|
| Critical Illness | 6 | 2023 | 806 | 0.360 |
Why?
|
| Urinary Tract Infections | 5 | 2022 | 192 | 0.360 |
Why?
|
| Kidney Failure, Chronic | 3 | 2013 | 574 | 0.360 |
Why?
|
| Thoracic Surgery | 2 | 2023 | 133 | 0.360 |
Why?
|
| Anesthesia | 3 | 2017 | 193 | 0.350 |
Why?
|
| Arterial Occlusive Diseases | 3 | 2006 | 85 | 0.340 |
Why?
|
| Shock, Septic | 2 | 2023 | 206 | 0.340 |
Why?
|
| Chi-Square Distribution | 11 | 2017 | 524 | 0.340 |
Why?
|
| Follow-Up Studies | 18 | 2015 | 5160 | 0.340 |
Why?
|
| Renal Replacement Therapy | 1 | 2011 | 89 | 0.340 |
Why?
|
| Neurosurgical Procedures | 3 | 2023 | 196 | 0.340 |
Why?
|
| Vascular Patency | 2 | 2008 | 111 | 0.330 |
Why?
|
| Carotid Stenosis | 2 | 2008 | 95 | 0.330 |
Why?
|
| Diabetes Mellitus | 8 | 2014 | 1054 | 0.320 |
Why?
|
| Pneumonectomy | 3 | 2019 | 150 | 0.320 |
Why?
|
| Parents | 6 | 2020 | 1419 | 0.320 |
Why?
|
| Popliteal Artery | 2 | 2008 | 62 | 0.320 |
Why?
|
| Age Factors | 15 | 2021 | 3262 | 0.320 |
Why?
|
| Body Mass Index | 11 | 2023 | 2382 | 0.320 |
Why?
|
| Obesity | 8 | 2023 | 2990 | 0.310 |
Why?
|
| Cardiac Surgical Procedures | 3 | 2023 | 538 | 0.310 |
Why?
|
| Troponin I | 2 | 2020 | 81 | 0.300 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2013 | 290 | 0.300 |
Why?
|
| Femoral Artery | 2 | 2008 | 182 | 0.290 |
Why?
|
| Smoking Cessation | 2 | 2011 | 431 | 0.290 |
Why?
|
| Graft Occlusion, Vascular | 2 | 2008 | 39 | 0.290 |
Why?
|
| Safety | 14 | 2007 | 345 | 0.290 |
Why?
|
| Coronary Artery Disease | 4 | 2008 | 698 | 0.290 |
Why?
|
| Cause of Death | 4 | 2017 | 425 | 0.280 |
Why?
|
| Early Detection of Cancer | 1 | 2013 | 432 | 0.280 |
Why?
|
| Data Collection | 9 | 2017 | 661 | 0.280 |
Why?
|
| Veins | 1 | 2008 | 65 | 0.280 |
Why?
|
| Cardiovascular Diseases | 10 | 2014 | 2042 | 0.270 |
Why?
|
| Respiration, Artificial | 4 | 2021 | 642 | 0.270 |
Why?
|
| Health Status | 10 | 2021 | 820 | 0.260 |
Why?
|
| Surveys and Questionnaires | 17 | 2020 | 5860 | 0.260 |
Why?
|
| Mastectomy | 2 | 2007 | 146 | 0.260 |
Why?
|
| Risk | 8 | 2017 | 908 | 0.260 |
Why?
|
| Prediabetic State | 3 | 2015 | 247 | 0.260 |
Why?
|
| Palate, Soft | 1 | 2006 | 15 | 0.260 |
Why?
|
| Blood Transfusion | 4 | 2015 | 339 | 0.260 |
Why?
|
| Pancreatic Neoplasms | 5 | 2017 | 856 | 0.250 |
Why?
|
| Lower Extremity | 2 | 2008 | 438 | 0.250 |
Why?
|
| Hip Fractures | 3 | 2013 | 86 | 0.250 |
Why?
|
| Postoperative Hemorrhage | 3 | 2023 | 85 | 0.240 |
Why?
|
| Acute Kidney Injury | 3 | 2011 | 806 | 0.240 |
Why?
|
| Sodium-Hydrogen Exchangers | 1 | 2005 | 23 | 0.240 |
Why?
|
| Esophagectomy | 4 | 2018 | 127 | 0.240 |
Why?
|
| Diabetes Mellitus, Type 2 | 4 | 2015 | 2513 | 0.230 |
Why?
|
| Angina, Unstable | 1 | 2005 | 78 | 0.230 |
Why?
|
| Health Behavior | 3 | 2018 | 775 | 0.230 |
Why?
|
| Glomerular Filtration Rate | 2 | 2008 | 746 | 0.230 |
Why?
|
| Cardiotonic Agents | 1 | 2005 | 92 | 0.230 |
Why?
|
| Continuity of Patient Care | 2 | 2019 | 282 | 0.230 |
Why?
|
| Factor Analysis, Statistical | 5 | 2020 | 292 | 0.220 |
Why?
|
| Propensity Score | 5 | 2019 | 312 | 0.220 |
Why?
|
| Alaska Natives | 2 | 2019 | 149 | 0.220 |
Why?
|
| Blood Glucose | 4 | 2023 | 2190 | 0.220 |
Why?
|
| Regression Analysis | 13 | 2012 | 1014 | 0.220 |
Why?
|
| Registries | 12 | 2013 | 2051 | 0.220 |
Why?
|
| Reproducibility of Results | 9 | 2020 | 3300 | 0.220 |
Why?
|
| Psychological Tests | 2 | 2015 | 135 | 0.220 |
Why?
|
| Motivational Interviewing | 2 | 2018 | 115 | 0.220 |
Why?
|
| Venous Thromboembolism | 2 | 2023 | 321 | 0.220 |
Why?
|
| Quality of Life | 10 | 2016 | 2952 | 0.220 |
Why?
|
| Hepatectomy | 5 | 2016 | 236 | 0.210 |
Why?
|
| Chronic Disease | 2 | 2013 | 1798 | 0.210 |
Why?
|
| Prognosis | 10 | 2021 | 4017 | 0.210 |
Why?
|
| Otorhinolaryngologic Surgical Procedures | 1 | 2004 | 38 | 0.210 |
Why?
|
| Patient Transfer | 3 | 2019 | 176 | 0.210 |
Why?
|
| Acidosis | 1 | 2005 | 103 | 0.210 |
Why?
|
| Palate | 1 | 2004 | 38 | 0.210 |
Why?
|
| Food Preferences | 2 | 2015 | 123 | 0.210 |
Why?
|
| Orthopedic Procedures | 3 | 2017 | 223 | 0.210 |
Why?
|
| Intraoperative Complications | 1 | 2005 | 139 | 0.210 |
Why?
|
| Infection Control | 3 | 2021 | 163 | 0.210 |
Why?
|
| Thromboembolism | 3 | 2011 | 117 | 0.210 |
Why?
|
| Diabetic Angiopathies | 3 | 2014 | 250 | 0.210 |
Why?
|
| Gastric Bypass | 3 | 2013 | 118 | 0.210 |
Why?
|
| Reoperation | 6 | 2023 | 585 | 0.200 |
Why?
|
| Thoracic Surgical Procedures | 2 | 2023 | 71 | 0.200 |
Why?
|
| Transients and Migrants | 1 | 2023 | 26 | 0.200 |
Why?
|
| Guideline Adherence | 3 | 2012 | 551 | 0.200 |
Why?
|
| Hernia, Hiatal | 1 | 2023 | 37 | 0.200 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2013 | 620 | 0.200 |
Why?
|
| Tidal Volume | 3 | 2017 | 88 | 0.200 |
Why?
|
| Anesthesia, Conduction | 2 | 2022 | 21 | 0.200 |
Why?
|
| Machine Learning | 4 | 2023 | 517 | 0.200 |
Why?
|
| Blood Loss, Surgical | 3 | 2017 | 101 | 0.200 |
Why?
|
| Perception | 3 | 2015 | 367 | 0.200 |
Why?
|
| Linear Models | 9 | 2020 | 851 | 0.200 |
Why?
|
| Stents | 3 | 2013 | 527 | 0.190 |
Why?
|
| Decision Support Techniques | 3 | 2014 | 424 | 0.190 |
Why?
|
| Alcoholism | 5 | 2013 | 819 | 0.190 |
Why?
|
| Vitamin K | 1 | 2002 | 42 | 0.190 |
Why?
|
| Pancreaticoduodenectomy | 3 | 2017 | 127 | 0.190 |
Why?
|
| Hospital Costs | 3 | 2011 | 118 | 0.190 |
Why?
|
| Coronary Disease | 1 | 2004 | 374 | 0.190 |
Why?
|
| Incidence | 9 | 2022 | 2820 | 0.190 |
Why?
|
| Activities of Daily Living | 3 | 2020 | 419 | 0.190 |
Why?
|
| Attitude of Health Personnel | 2 | 2014 | 1157 | 0.180 |
Why?
|
| Cognition Disorders | 3 | 2015 | 504 | 0.180 |
Why?
|
| Maternal Health Services | 1 | 2023 | 101 | 0.180 |
Why?
|
| Cystectomy | 3 | 2006 | 41 | 0.180 |
Why?
|
| Abdomen | 4 | 2017 | 128 | 0.180 |
Why?
|
| Predictive Value of Tests | 12 | 2019 | 2037 | 0.180 |
Why?
|
| Myocardial Revascularization | 3 | 2013 | 73 | 0.180 |
Why?
|
| Obesity, Morbid | 3 | 2012 | 265 | 0.180 |
Why?
|
| Child, Preschool | 13 | 2020 | 11115 | 0.180 |
Why?
|
| Pilot Projects | 5 | 2020 | 1743 | 0.180 |
Why?
|
| Warfarin | 1 | 2002 | 154 | 0.180 |
Why?
|
| Cardiomyopathies | 1 | 2005 | 322 | 0.170 |
Why?
|
| Cross Infection | 2 | 2015 | 250 | 0.170 |
Why?
|
| Health Knowledge, Attitudes, Practice | 4 | 2019 | 1367 | 0.170 |
Why?
|
| Randomized Controlled Trials as Topic | 6 | 2011 | 1479 | 0.170 |
Why?
|
| Research Design | 6 | 2014 | 1117 | 0.170 |
Why?
|
| Young Adult | 17 | 2019 | 13298 | 0.170 |
Why?
|
| Hematocrit | 4 | 2010 | 102 | 0.170 |
Why?
|
| Comprehension | 2 | 2014 | 175 | 0.170 |
Why?
|
| Gulf War | 4 | 2009 | 15 | 0.170 |
Why?
|
| Prunus persica | 1 | 2020 | 1 | 0.170 |
Why?
|
| Armillaria | 1 | 2020 | 3 | 0.170 |
Why?
|
| Abdominal Neoplasms | 2 | 2010 | 39 | 0.160 |
Why?
|
| Medicare | 2 | 2005 | 783 | 0.160 |
Why?
|
| Thoracic Neoplasms | 2 | 2010 | 37 | 0.160 |
Why?
|
| Adenocarcinoma | 2 | 2017 | 883 | 0.160 |
Why?
|
| Health Expenditures | 2 | 2012 | 193 | 0.160 |
Why?
|
| Antibiotic Prophylaxis | 2 | 2013 | 119 | 0.160 |
Why?
|
| Health Care Surveys | 4 | 2013 | 562 | 0.160 |
Why?
|
| Hospitals, University | 6 | 2018 | 179 | 0.160 |
Why?
|
| Premature Birth | 1 | 2023 | 340 | 0.160 |
Why?
|
| Thoracic Surgery, Video-Assisted | 1 | 2019 | 45 | 0.150 |
Why?
|
| Neoplasms | 5 | 2011 | 2694 | 0.150 |
Why?
|
| Thoracotomy | 1 | 2019 | 77 | 0.150 |
Why?
|
| Hernia, Inguinal | 3 | 2004 | 41 | 0.150 |
Why?
|
| Colectomy | 2 | 2011 | 101 | 0.150 |
Why?
|
| Safety Management | 3 | 2008 | 123 | 0.150 |
Why?
|
| Urinary Bladder Neoplasms | 3 | 2006 | 261 | 0.150 |
Why?
|
| Aftercare | 1 | 2020 | 210 | 0.150 |
Why?
|
| Leg | 3 | 2008 | 233 | 0.150 |
Why?
|
| Feasibility Studies | 3 | 2019 | 969 | 0.150 |
Why?
|
| Esophageal Neoplasms | 2 | 2018 | 321 | 0.140 |
Why?
|
| Occupational Health | 1 | 2021 | 204 | 0.140 |
Why?
|
| Outpatients | 1 | 2022 | 412 | 0.140 |
Why?
|
| Laryngeal Neoplasms | 2 | 2004 | 34 | 0.140 |
Why?
|
| Social Identification | 1 | 2019 | 68 | 0.140 |
Why?
|
| Total Quality Management | 4 | 2007 | 61 | 0.140 |
Why?
|
| Infant, Newborn | 6 | 2023 | 6133 | 0.140 |
Why?
|
| Adrenalectomy | 2 | 2008 | 65 | 0.140 |
Why?
|
| Lung Diseases | 3 | 2017 | 769 | 0.140 |
Why?
|
| Time | 3 | 2008 | 88 | 0.140 |
Why?
|
| Socioeconomic Factors | 4 | 2018 | 1308 | 0.140 |
Why?
|
| Arteriovenous Shunt, Surgical | 1 | 2017 | 19 | 0.140 |
Why?
|
| Thoracoscopy | 1 | 2017 | 54 | 0.130 |
Why?
|
| Neuromuscular Nondepolarizing Agents | 1 | 2017 | 15 | 0.130 |
Why?
|
| Digestive System Surgical Procedures | 3 | 2013 | 104 | 0.130 |
Why?
|
| Anti-Bacterial Agents | 3 | 2021 | 1808 | 0.130 |
Why?
|
| Perioperative Period | 2 | 2017 | 56 | 0.130 |
Why?
|
| Health Services Research | 4 | 2016 | 405 | 0.130 |
Why?
|
| Chemoradiotherapy, Adjuvant | 1 | 2017 | 43 | 0.130 |
Why?
|
| Selection Bias | 1 | 2017 | 39 | 0.130 |
Why?
|
| Clinical Competence | 1 | 2005 | 1123 | 0.130 |
Why?
|
| Lipoproteins, LDL | 2 | 2015 | 115 | 0.130 |
Why?
|
| Neuromuscular Blockade | 1 | 2017 | 36 | 0.130 |
Why?
|
| Alcohol Drinking | 3 | 2013 | 819 | 0.130 |
Why?
|
| Patient Selection | 4 | 2016 | 692 | 0.130 |
Why?
|
| Hospitals, High-Volume | 1 | 2016 | 44 | 0.130 |
Why?
|
| Proportional Hazards Models | 4 | 2015 | 1284 | 0.130 |
Why?
|
| Respiratory Insufficiency | 4 | 2017 | 317 | 0.130 |
Why?
|
| Diabetes Complications | 4 | 2008 | 226 | 0.130 |
Why?
|
| Cancer Care Facilities | 1 | 2016 | 43 | 0.130 |
Why?
|
| Polysomnography | 1 | 2017 | 203 | 0.120 |
Why?
|
| Intraoperative Care | 3 | 2015 | 58 | 0.120 |
Why?
|
| Mass Screening | 3 | 2013 | 1287 | 0.120 |
Why?
|
| Databases as Topic | 5 | 2008 | 69 | 0.120 |
Why?
|
| Hospitals | 2 | 2022 | 691 | 0.120 |
Why?
|
| Community Health Nursing | 1 | 2016 | 64 | 0.120 |
Why?
|
| Life Style | 2 | 2015 | 484 | 0.120 |
Why?
|
| Rectal Neoplasms | 1 | 2017 | 143 | 0.120 |
Why?
|
| Sense of Coherence | 1 | 2015 | 12 | 0.120 |
Why?
|
| Hypertension | 2 | 2015 | 1252 | 0.120 |
Why?
|
| Monitoring, Intraoperative | 1 | 2015 | 58 | 0.120 |
Why?
|
| Pneumonia, Bacterial | 1 | 2016 | 114 | 0.120 |
Why?
|
| Lung Neoplasms | 2 | 2019 | 2530 | 0.120 |
Why?
|
| Nasal Cavity | 1 | 2015 | 55 | 0.110 |
Why?
|
| Gastrectomy | 3 | 2008 | 131 | 0.110 |
Why?
|
| Physicians | 1 | 2004 | 926 | 0.110 |
Why?
|
| Carrier State | 1 | 2015 | 70 | 0.110 |
Why?
|
| Nomograms | 1 | 2015 | 55 | 0.110 |
Why?
|
| Venous Thrombosis | 2 | 2007 | 189 | 0.110 |
Why?
|
| Patient Care Team | 3 | 2014 | 636 | 0.110 |
Why?
|
| Health Personnel | 1 | 2021 | 723 | 0.110 |
Why?
|
| Trachea | 1 | 2016 | 249 | 0.110 |
Why?
|
| Adolescent | 13 | 2015 | 21503 | 0.110 |
Why?
|
| Health Education | 1 | 2018 | 355 | 0.110 |
Why?
|
| Vascular Diseases | 2 | 2008 | 241 | 0.110 |
Why?
|
| Dental Health Services | 1 | 2014 | 3 | 0.110 |
Why?
|
| Hypotension | 1 | 2015 | 118 | 0.110 |
Why?
|
| Case Management | 1 | 2014 | 67 | 0.110 |
Why?
|
| Attitude to Health | 1 | 2018 | 457 | 0.110 |
Why?
|
| Oral Hygiene | 1 | 2014 | 15 | 0.110 |
Why?
|
| Neoadjuvant Therapy | 1 | 2017 | 409 | 0.110 |
Why?
|
| Health Surveys | 5 | 2013 | 521 | 0.110 |
Why?
|
| Treatment Failure | 2 | 2021 | 350 | 0.110 |
Why?
|
| Intubation, Intratracheal | 1 | 2016 | 260 | 0.110 |
Why?
|
| Cerebrovascular Disorders | 1 | 2014 | 96 | 0.100 |
Why?
|
| Health Services, Indigenous | 1 | 2014 | 36 | 0.100 |
Why?
|
| Disease Management | 1 | 2017 | 620 | 0.100 |
Why?
|
| Renal Insufficiency | 3 | 2004 | 163 | 0.100 |
Why?
|
| Canada | 3 | 2021 | 409 | 0.100 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2016 | 359 | 0.100 |
Why?
|
| Blood Pressure | 3 | 2015 | 1730 | 0.100 |
Why?
|
| Prevalence | 8 | 2022 | 2744 | 0.100 |
Why?
|
| Racism | 1 | 2015 | 144 | 0.100 |
Why?
|
| Mastectomy, Segmental | 1 | 2013 | 96 | 0.100 |
Why?
|
| Primary Health Care | 2 | 2013 | 1775 | 0.100 |
Why?
|
| Internship and Residency | 3 | 2008 | 1173 | 0.100 |
Why?
|
| Vaginal Smears | 1 | 2013 | 61 | 0.100 |
Why?
|
| Pancreatectomy | 3 | 2016 | 241 | 0.100 |
Why?
|
| Meta-Analysis as Topic | 2 | 2023 | 186 | 0.100 |
Why?
|
| Societies, Medical | 3 | 2023 | 821 | 0.100 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 3 | 2012 | 1029 | 0.100 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2015 | 232 | 0.100 |
Why?
|
| Alaska | 4 | 2015 | 85 | 0.100 |
Why?
|
| Cost-Benefit Analysis | 4 | 2022 | 605 | 0.100 |
Why?
|
| Vaccination | 1 | 2021 | 1432 | 0.090 |
Why?
|
| Community Health Services | 1 | 2014 | 225 | 0.090 |
Why?
|
| Prejudice | 1 | 2013 | 72 | 0.090 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2015 | 266 | 0.090 |
Why?
|
| Twins | 2 | 2004 | 222 | 0.090 |
Why?
|
| Health Services Accessibility | 2 | 2013 | 999 | 0.090 |
Why?
|
| Colorectal Neoplasms | 2 | 2011 | 803 | 0.090 |
Why?
|
| Survivors | 1 | 2015 | 500 | 0.090 |
Why?
|
| Hyperglycemia | 1 | 2015 | 347 | 0.090 |
Why?
|
| Mammography | 1 | 2013 | 159 | 0.090 |
Why?
|
| Hospitals, Private | 2 | 2008 | 12 | 0.090 |
Why?
|
| Aging | 3 | 2013 | 1852 | 0.090 |
Why?
|
| Prostatectomy | 2 | 2010 | 102 | 0.090 |
Why?
|
| Diarrhea | 2 | 2022 | 184 | 0.090 |
Why?
|
| Patient Safety | 1 | 2014 | 320 | 0.090 |
Why?
|
| Weight Loss | 2 | 2013 | 785 | 0.090 |
Why?
|
| Severity of Illness Index | 7 | 2017 | 2857 | 0.090 |
Why?
|
| Staphylococcal Infections | 1 | 2015 | 386 | 0.090 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2011 | 75 | 0.090 |
Why?
|
| Infant | 4 | 2014 | 9553 | 0.080 |
Why?
|
| Epidemiologic Methods | 2 | 2008 | 95 | 0.080 |
Why?
|
| Prosthesis Implantation | 1 | 2012 | 155 | 0.080 |
Why?
|
| Hypoxia | 1 | 2017 | 1121 | 0.080 |
Why?
|
| Hypoglycemia | 1 | 2015 | 446 | 0.080 |
Why?
|
| Liver Neoplasms | 1 | 2016 | 762 | 0.080 |
Why?
|
| Hypoglycemic Agents | 2 | 2010 | 1302 | 0.080 |
Why?
|
| Pelvic Neoplasms | 1 | 2010 | 26 | 0.080 |
Why?
|
| Pregnancy Complications | 1 | 2015 | 532 | 0.080 |
Why?
|
| Practice Guidelines as Topic | 3 | 2013 | 1545 | 0.080 |
Why?
|
| Child | 7 | 2020 | 21862 | 0.080 |
Why?
|
| Brain Injuries | 1 | 2015 | 495 | 0.080 |
Why?
|
| Colorado | 5 | 2018 | 4526 | 0.080 |
Why?
|
| Hypolipidemic Agents | 1 | 2010 | 90 | 0.080 |
Why?
|
| Critical Care | 1 | 2015 | 617 | 0.080 |
Why?
|
| Algorithms | 4 | 2019 | 1709 | 0.080 |
Why?
|
| Cross-Sectional Studies | 5 | 2015 | 5518 | 0.080 |
Why?
|
| Laryngectomy | 2 | 2004 | 16 | 0.080 |
Why?
|
| Mental Processes | 1 | 2009 | 35 | 0.080 |
Why?
|
| Antihypertensive Agents | 1 | 2013 | 501 | 0.080 |
Why?
|
| Multicenter Studies as Topic | 3 | 2010 | 307 | 0.080 |
Why?
|
| Cardiovascular Surgical Procedures | 2 | 2009 | 30 | 0.080 |
Why?
|
| Job Satisfaction | 2 | 2008 | 215 | 0.080 |
Why?
|
| Computer Simulation | 1 | 2013 | 989 | 0.080 |
Why?
|
| Sensitivity and Specificity | 5 | 2018 | 1951 | 0.080 |
Why?
|
| Evidence-Based Medicine | 2 | 2011 | 740 | 0.080 |
Why?
|
| Communication | 3 | 2010 | 927 | 0.070 |
Why?
|
| Patients | 2 | 2007 | 176 | 0.070 |
Why?
|
| Dyslipidemias | 1 | 2010 | 169 | 0.070 |
Why?
|
| Kaplan-Meier Estimate | 4 | 2015 | 902 | 0.070 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2017 | 1305 | 0.070 |
Why?
|
| Drug Prescriptions | 1 | 2010 | 257 | 0.070 |
Why?
|
| Thinness | 1 | 2008 | 95 | 0.070 |
Why?
|
| Tibial Arteries | 1 | 2008 | 12 | 0.070 |
Why?
|
| Benchmarking | 2 | 2007 | 186 | 0.070 |
Why?
|
| Sex Factors | 4 | 2018 | 2055 | 0.070 |
Why?
|
| Emergencies | 2 | 2021 | 168 | 0.070 |
Why?
|
| Operating Rooms | 2 | 2007 | 124 | 0.070 |
Why?
|
| Endocrine Surgical Procedures | 1 | 2007 | 2 | 0.070 |
Why?
|
| Parathyroid Glands | 1 | 2007 | 10 | 0.070 |
Why?
|
| Anesthesia, General | 2 | 2022 | 80 | 0.070 |
Why?
|
| Health Promotion | 1 | 2014 | 745 | 0.070 |
Why?
|
| Polycythemia | 1 | 2007 | 22 | 0.070 |
Why?
|
| Health Plan Implementation | 1 | 2008 | 142 | 0.070 |
Why?
|
| Hospitals, Teaching | 1 | 2007 | 116 | 0.070 |
Why?
|
| Pulmonary Surgical Procedures | 1 | 2007 | 7 | 0.070 |
Why?
|
| Shoulder Joint | 1 | 2009 | 177 | 0.070 |
Why?
|
| Neuropsychological Tests | 2 | 2009 | 1050 | 0.070 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2008 | 88 | 0.070 |
Why?
|
| Inguinal Canal | 1 | 2006 | 11 | 0.060 |
Why?
|
| Thyroid Gland | 1 | 2007 | 91 | 0.060 |
Why?
|
| Caregivers | 4 | 2016 | 904 | 0.060 |
Why?
|
| Case-Control Studies | 3 | 2012 | 3574 | 0.060 |
Why?
|
| Operative Time | 2 | 2016 | 147 | 0.060 |
Why?
|
| Arteries | 1 | 2008 | 261 | 0.060 |
Why?
|
| Peptic Ulcer Hemorrhage | 1 | 2005 | 5 | 0.060 |
Why?
|
| Dapsone | 1 | 2005 | 7 | 0.060 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2013 | 855 | 0.060 |
Why?
|
| Vagotomy | 1 | 2005 | 33 | 0.060 |
Why?
|
| Laparotomy | 2 | 2004 | 111 | 0.060 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1991 | 646 | 0.060 |
Why?
|
| Sweet Syndrome | 1 | 2005 | 9 | 0.060 |
Why?
|
| Urethra | 1 | 2006 | 53 | 0.060 |
Why?
|
| Anemia | 1 | 2007 | 174 | 0.060 |
Why?
|
| Intestinal Obstruction | 1 | 2006 | 51 | 0.060 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2006 | 137 | 0.060 |
Why?
|
| Fracture Fixation, Internal | 1 | 2008 | 192 | 0.060 |
Why?
|
| Persian Gulf Syndrome | 1 | 2005 | 17 | 0.060 |
Why?
|
| Neoplasm Staging | 3 | 2016 | 1375 | 0.060 |
Why?
|
| Health Status Indicators | 1 | 2006 | 165 | 0.060 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2005 | 72 | 0.060 |
Why?
|
| Health Services Administration | 1 | 2005 | 8 | 0.060 |
Why?
|
| Spouses | 1 | 2006 | 104 | 0.060 |
Why?
|
| Osteoarthritis, Hip | 1 | 2005 | 47 | 0.060 |
Why?
|
| Reference Standards | 1 | 2005 | 184 | 0.060 |
Why?
|
| Interprofessional Relations | 1 | 2007 | 289 | 0.060 |
Why?
|
| Specialization | 1 | 2006 | 148 | 0.060 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2005 | 130 | 0.060 |
Why?
|
| Anesthesiology | 1 | 2006 | 90 | 0.060 |
Why?
|
| Seasons | 1 | 2007 | 538 | 0.060 |
Why?
|
| Drainage | 1 | 2005 | 174 | 0.060 |
Why?
|
| Delivery of Health Care | 1 | 2012 | 960 | 0.060 |
Why?
|
| Environmental Exposure | 1 | 2009 | 568 | 0.060 |
Why?
|
| Lung | 1 | 2017 | 4059 | 0.060 |
Why?
|
| Costs and Cost Analysis | 2 | 2003 | 218 | 0.060 |
Why?
|
| Dialysis | 1 | 2004 | 18 | 0.050 |
Why?
|
| Analysis of Variance | 3 | 2012 | 1314 | 0.050 |
Why?
|
| Southwestern United States | 2 | 2014 | 93 | 0.050 |
Why?
|
| Cardiac Output, Low | 1 | 2004 | 46 | 0.050 |
Why?
|
| Breast Neoplasms, Male | 1 | 2004 | 29 | 0.050 |
Why?
|
| Angina Pectoris | 1 | 2004 | 64 | 0.050 |
Why?
|
| Probability | 2 | 2020 | 308 | 0.050 |
Why?
|
| Geriatric Assessment | 3 | 2015 | 221 | 0.050 |
Why?
|
| Surgical Mesh | 1 | 2004 | 52 | 0.050 |
Why?
|
| Workload | 1 | 2005 | 162 | 0.050 |
Why?
|
| Erectile Dysfunction | 1 | 2004 | 40 | 0.050 |
Why?
|
| Developed Countries | 1 | 2023 | 39 | 0.050 |
Why?
|
| Hospitalization | 2 | 2016 | 2203 | 0.050 |
Why?
|
| Death | 1 | 2004 | 122 | 0.050 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2003 | 22 | 0.050 |
Why?
|
| Administration, Intravenous | 1 | 2023 | 154 | 0.050 |
Why?
|
| Herniorrhaphy | 1 | 2023 | 69 | 0.050 |
Why?
|
| Twin Studies as Topic | 1 | 2002 | 19 | 0.050 |
Why?
|
| Triglycerides | 2 | 2015 | 515 | 0.050 |
Why?
|
| Appendectomy | 1 | 2003 | 89 | 0.050 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2005 | 210 | 0.050 |
Why?
|
| Drug Therapy, Combination | 3 | 2013 | 1043 | 0.050 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2003 | 103 | 0.050 |
Why?
|
| Osteoarthritis, Knee | 1 | 2005 | 256 | 0.050 |
Why?
|
| Drug-Eluting Stents | 2 | 2013 | 82 | 0.050 |
Why?
|
| Stroke | 3 | 2011 | 1136 | 0.050 |
Why?
|
| Educational Status | 2 | 2018 | 474 | 0.050 |
Why?
|
| ROC Curve | 2 | 2019 | 565 | 0.050 |
Why?
|
| Residence Characteristics | 1 | 2005 | 366 | 0.050 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 1991 | 1755 | 0.050 |
Why?
|
| Decision Making | 3 | 2020 | 942 | 0.050 |
Why?
|
| Carcinoma, Small Cell | 1 | 2002 | 171 | 0.050 |
Why?
|
| Diseases in Twins | 1 | 2002 | 159 | 0.050 |
Why?
|
| Bayes Theorem | 1 | 2023 | 411 | 0.040 |
Why?
|
| Models, Theoretical | 2 | 2021 | 581 | 0.040 |
Why?
|
| Appendicitis | 1 | 2003 | 140 | 0.040 |
Why?
|
| Diabetic Retinopathy | 1 | 2003 | 190 | 0.040 |
Why?
|
| Feedback | 1 | 2002 | 173 | 0.040 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2009 | 847 | 0.040 |
Why?
|
| Erythropoietin | 1 | 2002 | 95 | 0.040 |
Why?
|
| Ischemia | 1 | 2004 | 411 | 0.040 |
Why?
|
| Radiotherapy, Adjuvant | 2 | 2016 | 215 | 0.040 |
Why?
|
| Clinical Trials as Topic | 1 | 2005 | 1032 | 0.040 |
Why?
|
| Stomach Neoplasms | 1 | 2002 | 118 | 0.040 |
Why?
|
| Observer Variation | 2 | 2015 | 349 | 0.040 |
Why?
|
| Postpartum Period | 1 | 2023 | 343 | 0.040 |
Why?
|
| Focus Groups | 1 | 2023 | 533 | 0.040 |
Why?
|
| Wounds and Injuries | 1 | 2007 | 760 | 0.040 |
Why?
|
| Creatinine | 1 | 2002 | 487 | 0.040 |
Why?
|
| Longitudinal Studies | 3 | 2015 | 2837 | 0.040 |
Why?
|
| Southeastern United States | 1 | 2020 | 31 | 0.040 |
Why?
|
| Fear | 1 | 2023 | 343 | 0.040 |
Why?
|
| Program Evaluation | 2 | 2019 | 911 | 0.040 |
Why?
|
| Intermediate Care Facilities | 1 | 2019 | 4 | 0.040 |
Why?
|
| Knowledge | 1 | 2020 | 57 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 2027 | 0.040 |
Why?
|
| Bacterial Infections | 1 | 2021 | 245 | 0.040 |
Why?
|
| Fruit | 1 | 2020 | 144 | 0.040 |
Why?
|
| Referral and Consultation | 1 | 2005 | 796 | 0.040 |
Why?
|
| Datasets as Topic | 1 | 2019 | 123 | 0.040 |
Why?
|
| Body Weight | 2 | 2017 | 985 | 0.040 |
Why?
|
| Age Distribution | 2 | 2013 | 397 | 0.040 |
Why?
|
| DMF Index | 1 | 2018 | 18 | 0.040 |
Why?
|
| Mental Disorders | 1 | 2007 | 1091 | 0.040 |
Why?
|
| Polymorphism, Genetic | 1 | 2021 | 634 | 0.040 |
Why?
|
| Overweight | 1 | 2023 | 571 | 0.040 |
Why?
|
| Soil | 1 | 2020 | 204 | 0.040 |
Why?
|
| Skilled Nursing Facilities | 1 | 2019 | 141 | 0.030 |
Why?
|
| Prone Position | 1 | 2017 | 26 | 0.030 |
Why?
|
| High-Frequency Ventilation | 1 | 2017 | 45 | 0.030 |
Why?
|
| Forecasting | 1 | 2019 | 384 | 0.030 |
Why?
|
| Neuromuscular Blocking Agents | 1 | 2017 | 25 | 0.030 |
Why?
|
| Blood Gas Analysis | 1 | 2017 | 79 | 0.030 |
Why?
|
| Snoring | 1 | 2017 | 14 | 0.030 |
Why?
|
| Neostigmine | 1 | 2017 | 10 | 0.030 |
Why?
|
| Anesthesia Recovery Period | 1 | 2017 | 22 | 0.030 |
Why?
|
| Psychology | 1 | 2018 | 87 | 0.030 |
Why?
|
| Anticoagulants | 1 | 2002 | 660 | 0.030 |
Why?
|
| Positive-Pressure Respiration | 1 | 2017 | 84 | 0.030 |
Why?
|
| Health Care Costs | 2 | 2014 | 418 | 0.030 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2017 | 34 | 0.030 |
Why?
|
| Pregnancy | 2 | 2023 | 6792 | 0.030 |
Why?
|
| Clinical Audit | 1 | 2016 | 14 | 0.030 |
Why?
|
| Income | 1 | 2018 | 204 | 0.030 |
Why?
|
| Colloids | 1 | 2017 | 60 | 0.030 |
Why?
|
| Oximetry | 1 | 2017 | 109 | 0.030 |
Why?
|
| Biomarkers | 1 | 2008 | 4101 | 0.030 |
Why?
|
| Matched-Pair Analysis | 1 | 2016 | 38 | 0.030 |
Why?
|
| Giant Cells | 1 | 2016 | 22 | 0.030 |
Why?
|
| Home Care Services | 1 | 2019 | 259 | 0.030 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2009 | 558 | 0.030 |
Why?
|
| Pelvis | 1 | 2017 | 107 | 0.030 |
Why?
|
| Recurrence | 3 | 2004 | 1102 | 0.030 |
Why?
|
| Language | 1 | 2019 | 301 | 0.030 |
Why?
|
| Lipoproteins, HDL | 1 | 2015 | 77 | 0.030 |
Why?
|
| Respiratory Tract Diseases | 1 | 2017 | 181 | 0.030 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2017 | 161 | 0.030 |
Why?
|
| Insurance, Dental | 1 | 2014 | 11 | 0.030 |
Why?
|
| Vulnerable Populations | 1 | 2016 | 164 | 0.030 |
Why?
|
| Dental Care for Children | 1 | 2014 | 12 | 0.030 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2016 | 377 | 0.030 |
Why?
|
| Blood Pressure Determination | 1 | 2015 | 143 | 0.030 |
Why?
|
| Fluorides, Topical | 1 | 2014 | 16 | 0.030 |
Why?
|
| Diet Surveys | 1 | 2014 | 96 | 0.030 |
Why?
|
| Cariostatic Agents | 1 | 2014 | 32 | 0.030 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2017 | 309 | 0.030 |
Why?
|
| International Classification of Diseases | 1 | 2015 | 138 | 0.030 |
Why?
|
| Midwestern United States | 1 | 2013 | 43 | 0.030 |
Why?
|
| Sodium Chloride Symporter Inhibitors | 1 | 2013 | 9 | 0.030 |
Why?
|
| Warfare | 2 | 2005 | 69 | 0.030 |
Why?
|
| Maternal Behavior | 1 | 2014 | 79 | 0.030 |
Why?
|
| Mastectomy, Modified Radical | 1 | 2013 | 6 | 0.030 |
Why?
|
| Longevity | 2 | 2005 | 174 | 0.030 |
Why?
|
| Cefazolin | 1 | 2013 | 20 | 0.030 |
Why?
|
| Smoking Prevention | 1 | 2014 | 182 | 0.030 |
Why?
|
| Nonlinear Dynamics | 1 | 2013 | 88 | 0.020 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2013 | 97 | 0.020 |
Why?
|
| Medical Records | 2 | 2005 | 183 | 0.020 |
Why?
|
| Rehabilitation Centers | 1 | 2013 | 38 | 0.020 |
Why?
|
| Mental Recall | 1 | 2014 | 206 | 0.020 |
Why?
|
| Vancomycin | 1 | 2013 | 79 | 0.020 |
Why?
|
| Risk Reduction Behavior | 1 | 2014 | 216 | 0.020 |
Why?
|
| Community-Based Participatory Research | 1 | 2014 | 157 | 0.020 |
Why?
|
| Calcium Channel Blockers | 1 | 2013 | 166 | 0.020 |
Why?
|
| Medical Record Linkage | 1 | 2013 | 65 | 0.020 |
Why?
|
| Hysterectomy | 1 | 2013 | 134 | 0.020 |
Why?
|
| Bias | 2 | 2005 | 224 | 0.020 |
Why?
|
| Cholesterol, LDL | 1 | 2014 | 359 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2013 | 343 | 0.020 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2013 | 196 | 0.020 |
Why?
|
| Serum Albumin | 2 | 2003 | 151 | 0.020 |
Why?
|
| Oxygen | 1 | 2017 | 957 | 0.020 |
Why?
|
| Energy Intake | 1 | 2015 | 506 | 0.020 |
Why?
|
| SEER Program | 1 | 2013 | 220 | 0.020 |
Why?
|
| Heart Failure | 1 | 2005 | 2053 | 0.020 |
Why?
|
| Urologic Diseases | 1 | 2011 | 39 | 0.020 |
Why?
|
| Quinolones | 1 | 2013 | 135 | 0.020 |
Why?
|
| Insulin | 2 | 2015 | 2405 | 0.020 |
Why?
|
| Mothers | 1 | 2018 | 763 | 0.020 |
Why?
|
| Forced Expiratory Volume | 1 | 2012 | 482 | 0.020 |
Why?
|
| Psychometrics | 1 | 2015 | 724 | 0.020 |
Why?
|
| Causality | 1 | 2011 | 128 | 0.020 |
Why?
|
| Urban Population | 1 | 2014 | 481 | 0.020 |
Why?
|
| Motor Activity | 1 | 2015 | 711 | 0.020 |
Why?
|
| Nursing Homes | 1 | 2013 | 174 | 0.020 |
Why?
|
| Self Report | 1 | 2015 | 839 | 0.020 |
Why?
|
| Streptonigrin | 1 | 2010 | 1 | 0.020 |
Why?
|
| Hemorrhage | 1 | 2015 | 720 | 0.020 |
Why?
|
| Fluorouracil | 1 | 1991 | 204 | 0.020 |
Why?
|
| Medication Adherence | 1 | 2014 | 503 | 0.020 |
Why?
|
| Commerce | 1 | 2011 | 81 | 0.020 |
Why?
|
| Medical Errors | 1 | 2011 | 112 | 0.020 |
Why?
|
| Cholecystectomy, Laparoscopic | 1 | 2010 | 52 | 0.020 |
Why?
|
| Poverty | 1 | 2014 | 522 | 0.020 |
Why?
|
| Rural Population | 1 | 2014 | 579 | 0.020 |
Why?
|
| Osteoporosis | 1 | 2012 | 244 | 0.020 |
Why?
|
| Hospitals, Military | 1 | 2009 | 26 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2011 | 501 | 0.020 |
Why?
|
| Cisplatin | 1 | 1991 | 327 | 0.020 |
Why?
|
| Sulfonylurea Compounds | 1 | 2008 | 50 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 2008 | 174 | 0.020 |
Why?
|
| Cost of Illness | 1 | 2010 | 309 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 1991 | 1238 | 0.020 |
Why?
|
| Patients' Rooms | 1 | 2007 | 13 | 0.020 |
Why?
|
| Diabetic Neuropathies | 1 | 2008 | 90 | 0.020 |
Why?
|
| Thiazolidinediones | 1 | 2008 | 139 | 0.020 |
Why?
|
| Intestinal Diseases | 1 | 2007 | 41 | 0.020 |
Why?
|
| Organizational Innovation | 1 | 2008 | 139 | 0.020 |
Why?
|
| Michigan | 1 | 2007 | 123 | 0.020 |
Why?
|
| Fracture Healing | 1 | 2008 | 83 | 0.020 |
Why?
|
| Likelihood Functions | 1 | 2007 | 143 | 0.020 |
Why?
|
| Current Procedural Terminology | 1 | 2006 | 16 | 0.020 |
Why?
|
| Psychotropic Drugs | 1 | 2007 | 73 | 0.020 |
Why?
|
| Transfusion Reaction | 1 | 2007 | 61 | 0.020 |
Why?
|
| Ventilator Weaning | 1 | 2006 | 37 | 0.020 |
Why?
|
| Efficiency, Organizational | 1 | 2007 | 139 | 0.020 |
Why?
|
| Diagnosis-Related Groups | 1 | 2006 | 31 | 0.020 |
Why?
|
| Organizational Culture | 1 | 2007 | 150 | 0.020 |
Why?
|
| Pediatrics | 1 | 2014 | 1073 | 0.020 |
Why?
|
| Tissue Adhesions | 1 | 2006 | 32 | 0.020 |
Why?
|
| Ileus | 1 | 2005 | 12 | 0.020 |
Why?
|
| Injury Severity Score | 1 | 2008 | 518 | 0.010 |
Why?
|
| Military Medicine | 1 | 2006 | 66 | 0.010 |
Why?
|
| Dyspepsia | 1 | 2005 | 10 | 0.010 |
Why?
|
| Fatigue Syndrome, Chronic | 1 | 2005 | 17 | 0.010 |
Why?
|
| Physician's Role | 1 | 2007 | 217 | 0.010 |
Why?
|
| Physician-Patient Relations | 1 | 2010 | 580 | 0.010 |
Why?
|
| Liver Failure | 1 | 2006 | 86 | 0.010 |
Why?
|
| Internal Mammary-Coronary Artery Anastomosis | 1 | 2004 | 3 | 0.010 |
Why?
|
| Life Expectancy | 1 | 2005 | 70 | 0.010 |
Why?
|
| Trauma Centers | 1 | 2007 | 416 | 0.010 |
Why?
|
| Fibromyalgia | 1 | 2005 | 53 | 0.010 |
Why?
|
| Coronary Restenosis | 1 | 2004 | 20 | 0.010 |
Why?
|
| Metformin | 1 | 2008 | 335 | 0.010 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2006 | 175 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 1991 | 1065 | 0.010 |
Why?
|
| Saphenous Vein | 1 | 2004 | 36 | 0.010 |
Why?
|
| Frail Elderly | 1 | 2005 | 130 | 0.010 |
Why?
|
| Cooperative Behavior | 1 | 2007 | 457 | 0.010 |
Why?
|
| Hypoalbuminemia | 1 | 2004 | 31 | 0.010 |
Why?
|
| Texas | 1 | 2005 | 253 | 0.010 |
Why?
|
| Gangrene | 1 | 2004 | 11 | 0.010 |
Why?
|
| Pulmonary Embolism | 1 | 2007 | 234 | 0.010 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2005 | 130 | 0.010 |
Why?
|
| Interviews as Topic | 1 | 2007 | 803 | 0.010 |
Why?
|
| Recovery of Function | 1 | 2008 | 666 | 0.010 |
Why?
|
| Skin Diseases | 1 | 2005 | 146 | 0.010 |
Why?
|
| Coma | 1 | 2003 | 35 | 0.010 |
Why?
|
| Blood Urea Nitrogen | 1 | 2003 | 54 | 0.010 |
Why?
|
| Bilirubin | 1 | 2003 | 89 | 0.010 |
Why?
|
| Vietnam | 1 | 2002 | 28 | 0.010 |
Why?
|
| Ascites | 1 | 2003 | 48 | 0.010 |
Why?
|
| Carotid Artery Diseases | 1 | 2002 | 61 | 0.010 |
Why?
|
| Molecular Epidemiology | 1 | 2002 | 71 | 0.010 |
Why?
|
| Health Services | 1 | 2003 | 116 | 0.010 |
Why?
|
| Alkaline Phosphatase | 1 | 2003 | 151 | 0.010 |
Why?
|
| Demography | 1 | 2002 | 296 | 0.010 |
Why?
|
| Injections, Subcutaneous | 1 | 2002 | 162 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 2002 | 198 | 0.010 |
Why?
|
| Wound Healing | 1 | 2004 | 346 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2002 | 704 | 0.010 |
Why?
|
| Burnout, Professional | 1 | 2007 | 443 | 0.010 |
Why?
|
| Dyspnea | 1 | 2003 | 251 | 0.010 |
Why?
|
| Intermittent Claudication | 1 | 2002 | 122 | 0.010 |
Why?
|
| Resuscitation | 1 | 2002 | 238 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 2002 | 362 | 0.010 |
Why?
|
| Stroke Volume | 1 | 2002 | 576 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2002 | 1354 | 0.010 |
Why?
|
| Kidney Diseases | 1 | 2002 | 407 | 0.010 |
Why?
|
| Blood Glucose Self-Monitoring | 1 | 2003 | 639 | 0.010 |
Why?
|
| Military Personnel | 1 | 2004 | 544 | 0.010 |
Why?
|
| Mental Health | 1 | 2003 | 735 | 0.010 |
Why?
|